![Chemistry / Tyrosine kinase inhibitors / Organochlorides / Organofluorides / Sulfonamides / Vemurafenib / BRAF / Hsp90 / Melanoma / Medicine / Biology / Oncogenes Chemistry / Tyrosine kinase inhibitors / Organochlorides / Organofluorides / Sulfonamides / Vemurafenib / BRAF / Hsp90 / Melanoma / Medicine / Biology / Oncogenes](https://www.pdfsearch.io/img/df95b9bb5a0b5d627c5f717649ee9394.jpg)
| Document Date: 2013-09-21 15:10:26 Open Document File Size: 516,79 KBShare Result on Facebook
City Hamburg / Cambridge / / Company Astex Pharmaceuticals Inc. / / Event FDA Phase / / IndustryTerm 2HP-β-cyclodextrin solution / / MedicalCondition BRAF mutant melanoma / SK-MEL-28R tumours / relapsed tumours / Male SCID / melanoma / resistant melanoma / AKT -resistant preclinical melanoma / resistant tumours / BRAFV600E-driven melanoma / SCID / BRAFV600E melanoma / delay disease / xenograft tumours / tumour / Western blot. resistant tumours / tumours / / Person Keisha Hearn / Jon Lewis / Mohammad Azab / Neil Thompson / Nicola Wallis / Tomoko Smyth / John Lyons / / Product AT13387 / / URL www.astx.com / /
SocialTag |